Buscar en
Enfermedades Infecciosas y Microbiología Clínica
Toda la web
Inicio Enfermedades Infecciosas y Microbiología Clínica Chlamydia pneumoniae Infection Associated to Acute Fibrinous and Organizing Pneu...
Información de la revista
Vol. 29. Núm. 8.
Páginas 632-634 (Octubre 2011)
Compartir
Compartir
Descargar PDF
Más opciones de artículo
Vol. 29. Núm. 8.
Páginas 632-634 (Octubre 2011)
Scientific letter
DOI: 10.1016/j.eimc.2011.01.018
Acceso a texto completo
Chlamydia pneumoniae Infection Associated to Acute Fibrinous and Organizing Pneumonia
Infección por Chlamydia pneumoniae asociada a neumonía aguda fibrinosa y en organización
Visitas
...
Alba Riberaa,??
Autor para correspondencia
aribera@bellvitgehospital.cat

Corresponding author.
, Roger Llatjósb, Aurora Casanovac, Miguel Santina
a Department of Infectious Diseases, Bellvitge University Hospital, Institut d’Investigació Biomèdica de Bellvitge (IDIBELL), University of Barcelona, L’Hospitalet de Llobregat, Barcelona, Spain
b Department of Pathology, Bellvitge University Hospital, Institut d’Investigació Biomèdica de Bellvitge (IDIBELL), University of Barcelona, L’Hospitalet de Llobregat, Barcelona, Spain
c Department of Microbiology, Bellvitge University Hospital, Institut d’Investigació Biomèdica de Bellvitge (IDIBELL), University of Barcelona, L’Hospitalet de Llobregat, Barcelona, Spain
Información del artículo
Texto completo
Bibliografía
Descargar PDF
Estadísticas
Figuras (2)
Tablas (1)
Table 1. Main characteristics of the four cases of C. pneumoniae infection associated with either BOOP or AFOP.
Texto completo
To the Editor:

Pneumonia with a mild prolonged course is the most frequent clinical presentation of the lower respiratory tract infection by Chlamydia pneumoniae.1 However, severe, life-threatening pneumonia has been reported, mainly in elderly hosts and those with chronic-associated conditions, but in previously healthy patients as well.1–5 Acute Fibrinous and Organizing Pneumonia (AFOP) is a histologic pattern associated with a clinical picture of acute lung injury which differs from the classic presentations of diffuse alveolar damage (DAD), bronchiolitis obliterans with organizing pneumonia (BOOP), and eosinophilic pneumonia (EP).1 Like these patterns, however, AFOP can occur in an idiopathic setting or in association with a wide spectrum of clinical conditions.6 The dominant histological finding in AFOP is the presence of intra-alveolar fibrin in the form of “fibrin balls” within the alveolar spaces.6 AFOP has a poor prognosis, with an overall mortality rate of about 50%.6

Here we present a case of Chlamydia pneumoniae infection associated with AFOP, respiratory failure, multi-organ dysfunction, and death. A 69-year-old woman with a history of hypertension, type II diabetes mellitus and chronic liver disease consulted for a four-day history of arthromyalgias, rhinorrhea, dry cough, fever, and progressive shortness of breath. She reported no relevant epidemiological history, such as exotic travel or contact with animals. She had received the influenza vaccine annually and pneumococcal vaccine the previous year. Her usual treatment was an ACE inhibitor and glibenclamide. At hospital admission, she was tachypneic (32 breathsmin−1); oxygen saturation was 92% breathing room air, blood pressure 120/60mmHg, pulse 111 beatsmin−1, and axillary temperature 37.9°C. Respiratory auscultation revealed crackles in both lower hemithoraces. Room air arterial blood gas determination showed acute respiratory hypoxia with an arterial oxygen tension (PaO2) of 8.3kPa (62mmHg), and arterial carbon dioxide tension (PaCO2) of 2.7kPa (20mmHg), a pH of 7.5, and oxygen saturation of 95.4%. Other notable laboratory findings were platelet count 34,000 cellsmm−3 (34.0 cells × 109·L−1), white blood cell count 3,900 cellsmm−3 (3.9 cells × 109·L−1) with 87% neutrophils, and Na+ 129 mmolL−1. Chest radiography revealed an alveolar consolidation in the right-middle and right-lower lobes and the lingula (Fig. 1). A sputum sample could not be obtained for examination. Urinary antigen detection by immunochromatography was negative for both Legionella pneumophila and Streptococcus pneumoniae. With the diagnosis of community-acquired pneumonia, the patient was treated with intravenous ceftriaxone (1g/day) and levofloxacin (500mg/day) for 24hours, followed by levofloxacin after establishing that urinary antigen for S. pneumoniae was negative. During the following two days, the patient's clinical condition deteriorated; consolidation on chest radiograph progressed and respiratory failure ensued, requiring transfer to the intensive care unit, invasive mechanical ventilation, and systemic corticosteroids. A chest computed tomographic scan showed areas of consolidation and ground glass opacities in the lower lobes. Studies for mycobacteria, fungi, conventional bacterial culture and viral cultures (Adenovirus, Influenza, Respiratory Syncytial Virus, Herpes simplex 1/2, Cytomegalovirus and Varicella Zoster) from a bronchoalveolar lavage were negative. Transbronchial biopsy showed an inflammatory process with a predominance of alveolar fibrin exudate in the form of “fibrin balls” without formation of hyaline membranes, and signs of organization compatible with AFOP (Fig. 2). Immunology was negative for vasculitis (anti-proteinase 3, anti-myeloperoxidase, and anti-glomerular basement membrane antibodies), and an echocardiography showed good global contractility and a pulmonary artery pressure of 4.9kPa (37mmHg). In spite of high doses of corticosteroids, respiratory distress and multiorgan dysfunction ensued and the patient died after 20 days of admission. Autopsy was not performed because it was not authorized by the family.

Figure 1.

Chest radiography: alveolar consolidation in the right-middle and right-lower lobes and the lingula.

(0,06MB).
Figure 2.

Transbronchial biopsy: intra-alveolar “fibrin balls” and fibroblastic tissue without hyaline membranes (hematoxylin-eosin ×100).

(0,72MB).

Serologies for Mycoplasma pneumoniae, Coxiella burnetti and Legionella pneumophila were negative. Chlamydia pneumoniae serology anti-IgG, using indirect microimmunofluorescence techniques (MIF, Focus Diagnostics) and Enzyme immunoassay (EIA, Savyon Diagnostics), showed a four-fold rise in IgG titers (1:32-1:512) between the first and second serum samples extracted 13 days apart. IgM detection was inconclusive by EIA.

Severe respiratory infection by C. pneumoniae occasionally has been associated with histological features of BOOP, which appeared to be secondary to the pulmonary infection.7-9 However, to our knowledge, no cases of C. pneumoniae infection associated with AFOP have been reported to date. Table 1 shows the main characteristics of the four cases of C. pneumoniae infection associated with BOOP reported in the literature, and the present case, associated with AFOP. All four patients were around the seventh decade of life: two of them had associated comorbidities and the other two were previously healthy. Chest radiographic findings differed slightly in the four cases, but alveolar infiltrates were always present. Three patients were treated with prednisone at doses 1mg/kg, in combination with an appropriate antimicrobial agent. All of them developed respiratory failure. The subsequent course was satisfactory under treatment in the three cases with BOOP. Despite appropriate antibiotic treatment and steroids, the clinical course of our patient was unsatisfactory and she died of respiratory failure. Treatment with steroids is almost always successful in BOOP, but are frequently less effective in AFOP due to the presence of fibrin in the alveolar spaces.10,11

Table 1.

Main characteristics of the four cases of C. pneumoniae infection associated with either BOOP or AFOP.

Patient num (reference)  Age/gender  Comorbidity  Chest radiography  PaO2 mmHg (FiO2 21%)  Serology C. pneumoniaeTreatment  Histology  Outcome 
          First  Second       
1 (7)  65/M  Wegener's granulomatosisImmunosuppressive treatmentRenal failure/ hemodialysisDiabetesAlcohol abuse/chronic pancreatitis  Diffuse reticulonodular and patchy opacities  58  Positive*  Positive*  DoxycyclinePrednisone  BOOP  Recovered 
2 (8)  70/M  Infiltration right lung  47  IgM: negativeIgG: 1/2,048  4096  DoxycyclinePrednisone (1mg/kg)  BOOP  Recovered 
3 (9)  70/M  Migratory infiltrates  54  IgM negativeIgG 1/256  2048  Minocycline  BOOP  Recovered 
4 (present case)  69/F  DiabetesChronic liver disease (HCV)  Bilateral consolidation  62  IgM negativeIgG 1/32  IgM inconclusiveIgG 1/512  LevofloxacinPrednisone (1mg/kg)  AFOP  Died 

BOOP: Bronchiolitis Obliterans with Organizing Pneumonia; AFOP: Acute Fibrinous and Organizing Pneumonia.

*

IgM and IgG titles are not detailed.

The case presented here illustrates that C. pneumoniae-associated AFOP should be considered in cases of atypical pneumonia with an unfavorable clinical evolution and that appropriate serological tests should be part of the etiological search in cases of BOOP or AFOP of unknown origin.

References
[1]
E. Balis, A. Boufas, I. Iliopoulos, N.J. Legakis, L. Zerva.
Severe Community-Acquired Pneumonia with Acute Hypoxemic Respiratory Failure Due to Primary Infection with Chlamydia pneumoniae in a Previously Healthy Adult.
Clin Infect Dis, 36 (2003), pp. e155-e157
[2]
P.E. Marik, J.I. Iglesias.
Severe community-acquired pneumonia, shock and multiorgan dysfunction syndrome caused by Chlamydia pneumoniae.
J Intern Med, 241 (1997), pp. 441-444
[3]
J. Gnarpe, H. Gnarpe, K. Nissen, K. Haldar, J. Nääs.
Chlamydia pneumoniae infection associated with multi-organ failure and fatal outcome in previously healthy patient.
Scand J Infect Dis, 30 (1998), pp. 523-524
[4]
P. Panagou, S. Tsipra, D. Bouros.
Adult respiratory distress syndrome due to Chlamydia pneumoniae in a young adult.
Respir Med, 90 (1996), pp. 311-313
[5]
A. Córdoba, J. Monterrubio, I. Bueno, G. Corcho.
Neumonía comunitaria grave por Chlamydia pneumoniae.
Emergencias, 18 (2006), pp. 263-264
[6]
M.D. Beasley, T.J. Franks, J.R. Galvin, B. Gouchuico, W.D. Travis.
Acute Fibrinous and Organizing Pneumonia. A histologic Pattern of Lung Injury and Possible Variant of Diffuse Alveolar Damage.
Arch Pathol Lab Med, 126 (2002), pp. 1064-1070
[7]
Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 48-1990. A 65-year-old man with pulmonary infiltrates after treatment for Wegener's granulomatosis. N Engl J Med. 1990;323:1546-55.
[8]
J.L. Diehl, M. Gisselbrecht, G. Meyer, D. Israel-Biet, H. Sors.
Bronchiolitis obliterans organizing pneumonia associated with chlamydial infection.
Eur Respir J, 9 (1996), pp. 1320-1322
[9]
S. Imokawa, K. Yasuda, H. Uchiyawa, S. Sagisaka, M. Harada, K. Mori, et al.
Chlamydial Infection Showing Migratory Pulmonar Infiltrates.
Nippon Naika Gakkai Zasshi, 46 (2007), pp. 1735-1738
[10]
A. Tzouvelekis, A. Koutsopoulos, A. Oikonomou, M. Froudarakis, P. Zaragoulidis, P. Steiropoulos, et al.
Acute Fibrinous and Organizing Pneumonia: a case report and review of the literature.
J Med Case Reports, 3 (2009), pp. 74
[11]
R. Gary, M.D. Epler.
Bronchiolitis Obliterans Organizing Pneumonia.
Arch Intern Med, 161 (2001), pp. 158-164
Copyright © 2010. Elsevier España, S.L.. All rights reserved
Opciones de artículo
Herramientas
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos

es en pt
Política de cookies Cookies policy Política de cookies
Utilizamos cookies propias y de terceros para mejorar nuestros servicios y mostrarle publicidad relacionada con sus preferencias mediante el análisis de sus hábitos de navegación. Si continua navegando, consideramos que acepta su uso. Puede cambiar la configuración u obtener más información aquí. To improve our services and products, we use "cookies" (own or third parties authorized) to show advertising related to client preferences through the analyses of navigation customer behavior. Continuing navigation will be considered as acceptance of this use. You can change the settings or obtain more information by clicking here. Utilizamos cookies próprios e de terceiros para melhorar nossos serviços e mostrar publicidade relacionada às suas preferências, analisando seus hábitos de navegação. Se continuar a navegar, consideramos que aceita o seu uso. Você pode alterar a configuração ou obter mais informações aqui.